ClinicalTrials.gov
ClinicalTrials.gov Menu

Internet-delivered Cognitive Behavioral Therapy (CBT) for Health Anxiety (Ha1b)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00828152
Recruitment Status : Completed
First Posted : January 23, 2009
Last Update Posted : May 6, 2015
Sponsor:
Information provided by:
Karolinska Institutet

Brief Summary:
Hypochondriasis (health anxiety) is common, has many negative consequences for the afflicted individual and is associated with high societal costs. Cognitive Behavioural Therapy (CBT) has proven to be effective when administered in live-sessions. The aim of this study is to investigate whether CBT remains effective when administered via a self-help programme on the Internet.

Condition or disease Intervention/treatment Phase
Hypochondriasis Behavioral: Internet-delivered CBT. Behavioral: On line discussion group Phase 2

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Internet-delivered Cognitive Behavioural Therapy for Health Anxiety - a Randomized Controlled Trial
Study Start Date : January 2009
Actual Primary Completion Date : June 2010
Actual Study Completion Date : July 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety

Arm Intervention/treatment
Experimental: 1
Internet-delivered CBT. Contact with therapist thru an e-mail system. 12 weeks.
Behavioral: Internet-delivered CBT.
12 weeks. Therapist contact through e-mail.

Placebo Comparator: 2
On line discussion group.
Behavioral: On line discussion group
Placebo. On line discussion group.




Primary Outcome Measures :
  1. Health Anxiety Inventory [ Time Frame: 3 days before treatment start ]
  2. Health Anxiety Inventory [ Time Frame: 12 weeks after pre asessment ]
  3. Health Anxiety Inventory [ Time Frame: 6 months after post assessment ]
  4. Health Anxiety Inventory [ Time Frame: 12 months after post assessment ]

Secondary Outcome Measures :
  1. IAS [ Time Frame: Immediately pre and post treatment,and 6 and 12 month follow up ]
  2. BAI [ Time Frame: Immediately pre and post treatment, and 6 and 12 month follow-up ]
  3. MADRS-S [ Time Frame: Immediately pre and post treatment, and 6 and 12 month follow-up ]
  4. QOLI [ Time Frame: Immediately pre and post treatment, and 6 and 12 month follow-up ]
  5. WI [ Time Frame: Immediately pre and post treatment, and 6 and 12 month follow-up ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Primary diagnosis of hypochondriasis
  • At least 18 years old
  • Able to read and write in swedish
  • Computer access

Exclusion Criteria:

  • Drug abuse
  • Concurrent severe depression
  • No serious somatic illness
  • Previous treatment with CBT for hypochondriasis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00828152


Locations
Sweden
Psykiatri Sydväst
Stockholm, Sweden, 141 86
Sponsors and Collaborators
Karolinska Institutet